ISSN 1016-5169 | E-ISSN 1308-4488
Venous thromboembolism studies of apixaban and its clinical use [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2016; 44(2): 41-46

Venous thromboembolism studies of apixaban and its clinical use

A. Kürşat Bozkurt
İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Kalp ve Damar Cerrahisi Anabilim Dalı, İstanbul

Traditional treatment of venous tromboembolism requieres initiation of anticoagulation with heparin and low molecular weight heparin which is followed by warfarin use between 3-6 months. Warfarin has a narrow therapeutic range and a wide range of food interactions. To overcome the difficulties of the treatment with warfarin, new oral anticoagulant agents (NOACs) had been discovered after long years of research processes. In this review, the use of these agents, especially of apixaban, will be discussed in the treatment of venous thromboembolism.

Keywords: Venous tromboembolism, heparin, anticoagulation.

How to cite this article
A. Kürşat Bozkurt. Venous thromboembolism studies of apixaban and its clinical use. Turk Kardiyol Dern Ars. 2016; 44(2): 41-46

Corresponding Author: A. Kürşat Bozkurt, Türkiye
Manuscript Language: Turkish

Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2024 Archives of the Turkish Society of Cardiology

Kare Publishing is a subsidiary of Kare Media.